Influence of Concomitant Ablation of Nonparoxysmal Atrial Fibrillation During Coronary Artery Bypass Grafting on Mortality and Readmissions

Authors

John A Treffalls
Katie J Hogan
Paige E Brlecic
Christopher B Sylvester
Todd K Rosengart
Joseph S Coselli
Marc R Moon
Ravi K Ghanta
Subhasis Chatterjee

Publication Date

12-1-2023

Journal

JTCVS Open

DOI

10.1016/j.xjon.2023.09.043

PMID

38204710

PMCID

PMC10775120

PubMedCentral® Posted Date

10-26-2023

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

coronary artery bypass grafting, atrial fibrillation, surgical ablation, readmissions, Nationwide Readmissions Database

Abstract

OBJECTIVE: We determined the utilization rate of surgical ablation (SA) during coronary artery bypass grafting (CABG) and compared outcomes between CABG with or without SA in a national cohort.

METHODS: The January 2016 to December 2018 Nationwide Readmissions Database was searched for all patients undergoing isolated CABG with preoperative persistent or chronic atrial fibrillation by using the International Classification of Diseases, 10th Revision classification. Propensity score matching and multivariate logistic regressions were performed to compare outcomes, and Cox proportional hazards model was used to assess risk factors for 1-year readmission.

RESULTS: Of 18,899 patients undergoing CABG with nonparoxysmal atrial fibrillation, 78% (n = 14,776) underwent CABG alone and 22% (n = 4123) underwent CABG with SA. In the propensity score-matched cohort (n = 8116), CABG with SA (n = 4054) (vs CABG alone [n = 4112]) was not associated with increased in-hospital mortality (3.4% [139 out of 4112] vs 3.9% [159 ut of 4054]; P = .4), index-hospitalization length of stay (10 days vs 10 days; P = .3), 30-day readmission (19.1% [693 out of 3362] vs 17.2% [609 out of 3537]; P = .2), or 90-day readmission (28.9% [840 out of 2911] vs 26.2% [752 out of 2875]; P = .1). Index hospitalization costs were significantly higher for those undergoing SA ($52,556 vs $47,433; P < .001). Rates of readmission at 300 days were similar between patients receiving SA (43.8%) and no SA (42.8%; log-rank P = .3). The 3 most common causes of readmission were not different between groups and included heart failure (24.3% [594 out of 2444]; P = .6), infection (16.8% [411 out of 2444]; P = .5), and arrhythmia (11.7% [286 out of 2444]; P = .2).

CONCLUSIONS: In patients with nonparoxysmal atrial fibrillation, utilization of SA during CABG remains low. SA during CABG did not adversely influence mortality or short-term readmissions. These findings support increased use of SA during CABG.